Dexcom Clarity
Data analysis and reporting platform for glucose monitoring
Platform · Cloud SaaSCompany source
Company profile
About Dexcom
Dexcom is a global leader in continuous glucose monitoring, providing real-time glucose data and AI-powered insights for diabetes management.
Company description Dexcom official website
Primary marketChronic Disease Management & Digital Therapeutics
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at Dexcom?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Diabetes (all types)
- General glucose health monitoring
- Glucose dysregulation
- Prediabetes
Who it serves
- Clinical Research organizations
- Consumers with diabetes
- Health Systems
- Healthcare Professionals
Deployment & integration
Cloud Saas · Embedded deployment with recorded integration context.
Recorded integration context: AID (Automated Insulin Delivery) Algorithms, Connected Insulin Pens and Caps, Connected Insulin Pumps, Digital Health Apps, Health Systems Data Integrations, Wearable Devices.
Geographic context
MarketsInternational markets (reviewing partnerships outside US) · United States
Company sourceOfficial website
Company milestones
Platform expansion
Launched Stelo as first over-the-counter CGM (2024-2025). Introduced Dexcom G7 direct-to-watch feature. Formed Customer Advisory Council in January 2026. Celebrating 25+ years in glucose biosensing technology.
Partnerships
Recorded partners
- Clinical research organizations
- Connected insulin pump manufacturers
- Digital health app developers
- Health systems
- Wearable device companies
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Dexcom Follow
Companion app for remote glucose monitoring
Software · Cloud SaaSCompany source
Dexcom G7
The world's most powerful CGM system with best-in-class accuracy
Device · EmbeddedCompany source
Dexcom G7 15 Day
Extended 15-day wear continuous glucose monitoring system
Device · EmbeddedCompany source
Dexcom Share
Remote glucose monitoring and sharing platform
Software · Cloud SaaSCompany source
Stelo Glucose Biosensor
First over-the-counter CGM for personalized glucose insights without prescription
Device · EmbeddedCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Continuous Glucose Monitoring-Informed Basal Insulin Optimization System in Adults with Type 2 Diabetes: Initial Evaluation of Efficacy, Safety, and Impact on Patient-Reported Outcomes.Diabetes therapy : research, treatment and education of diabetes and related disorders · Aug 10, 2026
Real-time continuous glucose monitoring related to reductions in inpatient and emergency department encounters and their associated costs among non-insulin-treated people with type 2 diabetes.Journal of managed care & specialty pharmacy · Jul 21, 2026
Digital phenotyping of CGM engagement reveals distinct glycemic outcomes.PLOS digital health · Jul 1, 2026
Feasibility and benefits of continuous glucose monitoring for type 1 diabetes in Rwanda: A real-world 12-month continuation phase.Diabetic medicine : a journal of the British Diabetic Association · Jul 1, 2026
Clinical Impact of Continuous Glucose Monitoring in Noninsulin Treated Type 2 Diabetes: A Review.Diabetes technology & therapeutics · Jul 1, 2026
Workshop on Noninvasive Glucose Monitoring 2025.Journal of diabetes science and technology · Jul 1, 2026
Clinical validation
Clinical-trial records
The YMCA Healthy Lifestyle Program for PrediabetesNCT06841796 · Sponsor · ACTIVE NOT RECRUITING
Diabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved PopulationsNCT06939413 · Sponsor · ACTIVE NOT RECRUITING
REAL-Fam Feasibility Study for Youth Diabetes ManagementNCT07212790 · Sponsor · ACTIVE NOT RECRUITING
CONtiNuous glucosE Monitoring (CGM) in People wiTh Type 2 Diabetes Not on InsulinNCT06601166 · Sponsor · ACTIVE NOT RECRUITING
Continuous Glucose Monitoring in At-Risk NewbornsNCT04386005 · Sponsor · COMPLETED
Continuous Glucose Monitoring Following Hospital DischargeNCT05360056 · Sponsor · ACTIVE NOT RECRUITING
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Best-in-class accuracy
CGM system accuracy for glucose monitoring
73.9% sensor life
Sensors lasting full 15 days
Real-time glucose monitoring
5-minute reading intervals
Lance Bass
Personal glucose monitoring and diabetes management
Receives new glucose reading every 5 minutes, eliminating guesswork in glucose management
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Jake Leach
President and Chief Executive Officer
Sumi Shrishrimal, CPA, CISA
Vice President Internal Audit
Matt Dolan
Executive Vice President, Strategy, Corporate Development & Dexcom Labs
Don Abbey
Executive Vice President
Sayron Ruiz
Vice President Operations
bill Stack
Chief Technology Officer
Jereme Sylvain
EVP, Chief Financial Officer
Deniz Ünal
Chief of Staff
06 · Company updates
Updates from Dexcom
Recent articles published on Dexcom's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Chronic Disease Management & Digital Therapeutics
Companies using AI and digital health tools to help patients manage chronic conditions through digital therapeutics, gamified health management, and AI-powered coaching. Covers management of all chronic diseases including diabetes, hypertension, COPD, heart disease, and multi-condition platforms. Includes continuous glucose monitoring (CGM) systems with AI analytics and insulin optimization algorithms.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.